Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

SHE:000739 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	3,574	3,662	3,581	3,553	2,610	2,194
Trading Asset Securities	-	-	-	0.09	14.89	116.22
Cash & Short-Term Investments	3,574	3,662	3,581	3,553	2,625	2,310
Cash Growth	-9.48%	2.26%	0.78%	35.35%	13.61%	54.06%
Accounts Receivable	2,294	2,265	2,243	2,040	1,523	1,256
Other Receivables	134.32	112.26	114.46	116.28	103.74	61.54
Receivables	2,429	2,433	2,421	2,156	1,626	1,318
Inventory	1,694	1,860	2,083	1,802	1,250	1,086
Prepaid Expenses	6.32	4.64	26.65	20.59	13.06	16.04
Other Current Assets	308.98	227.8	256.96	249.5	267.72	187.1
Total Current Assets	8,012	8,187	8,368	7,781	5,782	4,917
Property, Plant & Equipment	3,662	3,775	3,564	3,406	2,588	1,981
Long-Term Investments	143.53	139.66	174.05	91.41	81.25	121.74
Goodwill	20.31	20.31	20.31	20.31	20.31	20.31
Other Intangible Assets	305.54	314.61	319.8	338.93	346.05	339.9
Long-Term Deferred Tax Assets	217.05	227.66	247.4	270.29	47.58	39.57
Long-Term Deferred Charges	55.13	15.77	20.57	66.21	46.76	11.96
Other Long-Term Assets	63.99	49.32	53.75	47.15	133.22	62.69
Total Assets	12,484	12,729	12,768	12,021	9,045	7,495
Accounts Payable	3,584	3,633	4,127	4,311	2,623	1,929
Accrued Expenses	215.8	251.62	226.43	202.82	221.62	249.4
Short-Term Debt	939.55	814.03	807.8	562.81	332.47	330.28
Current Portion of Long-Term Debt	5.01	5	81.34	0.4	0.2	-
Current Portion of Leases	4.09	6.61	7.98	8.65	13.77	-
Current Income Taxes Payable	69.57	92.33	77.04	80.59	120.56	131.04
Current Unearned Revenue	149.31	514.33	430.37	458.26	302.4	136.19
Other Current Liabilities	414.78	425.26	550.05	402.44	165.8	120.88
Total Current Liabilities	5,382	5,743	6,308	6,027	3,779	2,896
Long-Term Debt	223.12	70.05	18.71	249.62	104.94	-
Long-Term Leases	13.89	13.78	4.47	15.81	22.95	-
Long-Term Unearned Revenue	31.36	31.69	30.62	15.12	1.17	125.43
Long-Term Deferred Tax Liabilities	76.71	84.98	103.71	122.96	4.25	10.22
Other Long-Term Liabilities	-	36	72	72	72	72
Total Liabilities	5,727	5,979	6,537	6,502	3,985	3,104
Common Stock	1,158	1,169	1,179	1,179	1,179	1,179
Additional Paid-In Capital	104.79	247	438.01	438.01	438.01	438.01
Retained Earnings	5,631	5,481	4,804	4,096	3,443	2,774
Treasury Stock	-143.6	-153.09	-200.2	-200.2	-	-
Comprehensive Income & Other	-1.7	-2.02	2.01	-0.79	0.43	0.27
Total Common Equity	6,749	6,742	6,223	5,512	5,060	4,391
Minority Interest	7.94	7.92	7.69	7.35	-	-
Shareholders' Equity	6,757	6,750	6,230	5,519	5,060	4,391
Total Liabilities & Equity	12,484	12,729	12,768	12,021	9,045	7,495
Total Debt	1,186	909.47	920.3	837.3	474.33	330.28
Net Cash (Debt)	2,388	2,752	2,660	2,716	2,151	1,980
Net Cash Growth	-19.58%	3.45%	-2.04%	26.27%	8.61%	36.59%
Net Cash Per Share	2.06	2.37	2.28	2.31	1.82	1.68
Filing Date Shares Outstanding	1,148	1,158	1,169	1,169	1,179	1,179
Total Common Shares Outstanding	1,148	1,158	1,169	1,169	1,179	1,179
Working Capital	2,630	2,444	2,060	1,755	2,003	2,021
Book Value Per Share	5.88	5.82	5.32	4.71	4.29	3.73
Tangible Book Value	6,423	6,407	5,883	5,153	4,694	4,030
Tangible Book Value Per Share	5.59	5.53	5.03	4.41	3.98	3.42
Buildings	2,036	1,991	1,743	1,743	1,474	1,456
Machinery	4,900	4,767	4,398	4,126	2,903	2,755
Construction In Progress	377.29	407.48	545.85	311.4	710.22	158.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.